In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease
Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possi...
Gespeichert in:
| Veröffentlicht in: | Molecular therapy. Nucleic acids Jg. 3; H. 2; S. e146 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Elsevier Inc
01.02.2014
Elsevier Limited Nature Publishing Group Elsevier |
| Schlagworte: | |
| ISSN: | 2162-2531, 2162-2531 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possible curative approach involves the introduction of DNA double strand breaks in latent HSV genomes by rare-cutting endonucleases, leading to mutagenesis of essential viral genes. We tested this approach in an in vitro HSV latency model using the engineered homing endonuclease (HE) HSV1m5, which recognizes a sequence in the HSV-1 gene UL19, encoding the virion protein VP5. Coexpression of the 3′-exonuclease Trex2 with HEs increased HE-mediated mutagenesis frequencies up to sixfold. Following HSV1m5/Trex2 delivery with adeno-associated viral (AAV) vectors, the target site was mutated in latent HSV genomes with no detectable cell toxicity. Importantly, HSV production by latently infected cells after reactivation was decreased after HSV1m5/Trex2 exposure. Exposure to histone deacetylase inhibitors prior to HSV1m5/Trex2 treatment increased mutagenesis frequencies of latent HSV genomes another two- to fivefold, suggesting that chromatin modification may be a useful adjunct to gene-targeting approaches. These results support the continuing development of HEs and other nucleases (ZFNs, TALENs, CRISPRs) for cure of chronic viral infections. |
|---|---|
| AbstractList | Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possible curative approach involves the introduction of DNA double strand breaks in latent HSV genomes by rare-cutting endonucleases, leading to mutagenesis of essential viral genes. We tested this approach in an in vitro HSV latency model using the engineered homing endonuclease (HE) HSV1m5, which recognizes a sequence in the HSV-1 gene UL19, encoding the virion protein VP5. Coexpression of the 3'-exonuclease Trex2 with HEs increased HE-mediated mutagenesis frequencies up to sixfold. Following HSV1m5/Trex2 delivery with adeno-associated viral (AAV) vectors, the target site was mutated in latent HSV genomes with no detectable cell toxicity. Importantly, HSV production by latently infected cells after reactivation was decreased after HSV1m5/Trex2 exposure. Exposure to histone deacetylase inhibitors prior to HSV1m5/Trex2 treatment increased mutagenesis frequencies of latent HSV genomes another two- to fivefold, suggesting that chromatin modification may be a useful adjunct to gene-targeting approaches. These results support the continuing development of HEs and other nucleases (ZFNs, TALENs, CRISPRs) for cure of chronic viral infections.Molecular Therapy-Nucleic Acids (2014) 3, e1; doi:10.1038/mtna.2013.75; published online 4 February 2014. Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possible curative approach involves the introduction of DNA double strand breaks in latent HSV genomes by rare-cutting endonucleases, leading to mutagenesis of essential viral genes. We tested this approach in an in vitro HSV latency model using the engineered homing endonuclease (HE) HSV1m5, which recognizes a sequence in the HSV-1 gene UL19, encoding the virion protein VP5. Coexpression of the 3′-exonuclease Trex2 with HEs increased HE-mediated mutagenesis frequencies up to sixfold. Following HSV1m5/Trex2 delivery with adeno-associated viral (AAV) vectors, the target site was mutated in latent HSV genomes with no detectable cell toxicity. Importantly, HSV production by latently infected cells after reactivation was decreased after HSV1m5/Trex2 exposure. Exposure to histone deacetylase inhibitors prior to HSV1m5/Trex2 treatment increased mutagenesis frequencies of latent HSV genomes another two- to fivefold, suggesting that chromatin modification may be a useful adjunct to gene-targeting approaches. These results support the continuing development of HEs and other nucleases (ZFNs, TALENs, CRISPRs) for cure of chronic viral infections. Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possible curative approach involves the introduction of DNA double strand breaks in latent HSV genomes by rare-cutting endonucleases, leading to mutagenesis of essential viral genes. We tested this approach in an in vitro HSV latency model using the engineered homing endonuclease (HE) HSV1m5, which recognizes a sequence in the HSV-1 gene U sub(L)19, encoding the virion protein VP5. Coexpression of the 3'-exonuclease Trex2 with HEs increased HE-mediated mutagenesis frequencies up to sixfold. Following HSV1m5/Trex2 delivery with adeno-associated viral (AAV) vectors, the target site was mutated in latent HSV genomes with no detectable cell toxicity. Importantly, HSV production by latently infected cells after reactivation was decreased after HSV1m5/Trex2 exposure. Exposure to histone deacetylase inhibitors prior to HSV1m5/Trex2 treatment increased mutagenesis frequencies of latent HSV genomes another two- to fivefold, suggesting that chromatin modification may be a useful adjunct to gene-targeting approaches. These results support the continuing development of HEs and other nucleases (ZFNs, TALENs, CRISPRs) for cure of chronic viral infections.Molecular Therapy-Nucleic Acids (2014) 3, e1; doi:10.1038/mtna.2013.75; published online 4 February 2014 Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possible curative approach involves the introduction of DNA double strand breaks in latent HSV genomes by rare-cutting endonucleases, leading to mutagenesis of essential viral genes. We tested this approach in an in vitro HSV latency model using the engineered homing endonuclease (HE) HSV1m5, which recognizes a sequence in the HSV-1 gene U L 19, encoding the virion protein VP5. Coexpression of the 3[variant prime]-exonuclease Trex2 with HEs increased HE-mediated mutagenesis frequencies up to sixfold. Following HSV1m5/Trex2 delivery with adeno-associated viral (AAV) vectors, the target site was mutated in latent HSV genomes with no detectable cell toxicity. Importantly, HSV production by latently infected cells after reactivation was decreased after HSV1m5/Trex2 exposure. Exposure to histone deacetylase inhibitors prior to HSV1m5/Trex2 treatment increased mutagenesis frequencies of latent HSV genomes another two- to fivefold, suggesting that chromatin modification may be a useful adjunct to gene-targeting approaches. These results support the continuing development of HEs and other nucleases (ZFNs, TALENs, CRISPRs) for cure of chronic viral infections.Molecular Therapy--Nucleic Acids (2014) 3, e1; doi:10.1038/mtna.2013.75; published online 4 February 2014 Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possible curative approach involves the introduction of DNA double strand breaks in latent HSV genomes by rare-cutting endonucleases, leading to mutagenesis of essential viral genes. We tested this approach in an in vitro HSV latency model using the engineered homing endonuclease (HE) HSV1m5, which recognizes a sequence in the HSV-1 gene UL19, encoding the virion protein VP5. Coexpression of the 3'-exonuclease Trex2 with HEs increased HE-mediated mutagenesis frequencies up to sixfold. Following HSV1m5/Trex2 delivery with adeno-associated viral (AAV) vectors, the target site was mutated in latent HSV genomes with no detectable cell toxicity. Importantly, HSV production by latently infected cells after reactivation was decreased after HSV1m5/Trex2 exposure. Exposure to histone deacetylase inhibitors prior to HSV1m5/Trex2 treatment increased mutagenesis frequencies of latent HSV genomes another two- to fivefold, suggesting that chromatin modification may be a useful adjunct to gene-targeting approaches. These results support the continuing development of HEs and other nucleases (ZFNs, TALENs, CRISPRs) for cure of chronic viral infections.Molecular Therapy-Nucleic Acids (2014) 3, e1; doi:10.1038/mtna.2013.75; published online 4 February 2014.Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease. Available antiviral therapies do not affect latent viral genomes; therefore, they do not prevent reactivation following therapy cessation. One possible curative approach involves the introduction of DNA double strand breaks in latent HSV genomes by rare-cutting endonucleases, leading to mutagenesis of essential viral genes. We tested this approach in an in vitro HSV latency model using the engineered homing endonuclease (HE) HSV1m5, which recognizes a sequence in the HSV-1 gene UL19, encoding the virion protein VP5. Coexpression of the 3'-exonuclease Trex2 with HEs increased HE-mediated mutagenesis frequencies up to sixfold. Following HSV1m5/Trex2 delivery with adeno-associated viral (AAV) vectors, the target site was mutated in latent HSV genomes with no detectable cell toxicity. Importantly, HSV production by latently infected cells after reactivation was decreased after HSV1m5/Trex2 exposure. Exposure to histone deacetylase inhibitors prior to HSV1m5/Trex2 treatment increased mutagenesis frequencies of latent HSV genomes another two- to fivefold, suggesting that chromatin modification may be a useful adjunct to gene-targeting approaches. These results support the continuing development of HEs and other nucleases (ZFNs, TALENs, CRISPRs) for cure of chronic viral infections.Molecular Therapy-Nucleic Acids (2014) 3, e1; doi:10.1038/mtna.2013.75; published online 4 February 2014. |
| ArticleNumber | e146 |
| Author | Aubert, Martine Magaret, Amalia S Scharenberg, Andrew M Huang, Meei-Li Galetto, Roman Stone, Daniel Stensland, Laurence Boyle, Nicole M Jerome, Keith R Rawlings, David J |
| Author_xml | – sequence: 1 givenname: Martine surname: Aubert fullname: Aubert, Martine organization: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA – sequence: 2 givenname: Nicole M surname: Boyle fullname: Boyle, Nicole M organization: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA – sequence: 3 givenname: Daniel surname: Stone fullname: Stone, Daniel organization: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA – sequence: 4 givenname: Laurence surname: Stensland fullname: Stensland, Laurence organization: Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA – sequence: 5 givenname: Meei-Li surname: Huang fullname: Huang, Meei-Li organization: Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA – sequence: 6 givenname: Amalia S surname: Magaret fullname: Magaret, Amalia S organization: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA – sequence: 7 givenname: Roman surname: Galetto fullname: Galetto, Roman organization: Cellectis Therapeutics, Paris, France – sequence: 8 givenname: David J surname: Rawlings fullname: Rawlings, David J organization: Department of Pediatrics, University of Washington, Seattle, Washington, USA – sequence: 9 givenname: Andrew M surname: Scharenberg fullname: Scharenberg, Andrew M organization: Cellectis Therapeutics, Paris, France – sequence: 10 givenname: Keith R surname: Jerome fullname: Jerome, Keith R email: kjerome@fhcrc.org organization: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24496438$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1vEzEQhleoiJbQG2dkiQsHEvyxXu9ekFBVSKQgDrRcLX_MBkcbO9jeSP33eJsWtRUIX2yN33k08868rE588FBVrwleEMzaD7vs1YJiwhaCP6vOKGnonHJGTh68T6vzlLa4nAYT2tAX1Smt666pWXtWwcqjg8sxoJVXJruDyi54FHq0Vhl8RsvvP5C-QVcqbiCDRV_HrDbgIbmErpPzG6T8JJqnPRjXO4OWYTeFL70NfjQDqASvque9GhKc392z6vrz5dXFcr7-9mV18Wk9N5y3eW56Y7GhVGBrrMC60ZRbTHqmtW1EzXsu6tYwQ3QtNKcd0VgZwTtuLG9b1rJZtTpybVBbuY9up-KNDMrJ20CIG6lidqUoKYozHLiFzkDNVNupXjRYC0IU16K3hfXxyNqPegfWFDOiGh5BH_9491NuwkGyjpOOkAJ4dweI4dcIKcudSwaGQXkIY5KkxW3DsGj5_6V1V4iiFlOLb59It2GMvrgqiegaVuOadEX15mHxf6q-H3wR0KPAxJBShF4al29nX3pxgyRYTgsmpwWT04JNhs2q90-S7rn_kDdHOZSRHxxEmYwDb8C6CCaXmbi_J_4GNAzkEQ |
| CitedBy_id | crossref_primary_10_1038_s41598_017_01004_y crossref_primary_10_1089_apc_2016_0232 crossref_primary_10_1016_j_omtm_2020_05_011 crossref_primary_10_1016_j_vaccine_2017_09_044 crossref_primary_10_1038_s41467_020_17936_5 crossref_primary_10_4254_wjh_v7_i6_859 crossref_primary_10_3390_v13020338 crossref_primary_10_1016_j_antiviral_2015_12_007 crossref_primary_10_3390_v14020378 crossref_primary_10_1016_j_virol_2013_12_037 crossref_primary_10_1093_jac_dkw104 crossref_primary_10_1038_mt_2016_10 crossref_primary_10_1097_OLQ_0000000000000493 crossref_primary_10_1016_j_omtm_2024_101303 crossref_primary_10_1371_journal_pone_0097579 crossref_primary_10_1007_s40778_014_0008_7 crossref_primary_10_1083_jcb_202304106 crossref_primary_10_1038_srep20064 crossref_primary_10_1080_14787210_2017_1400379 crossref_primary_10_1097_ICL_0000000000000952 crossref_primary_10_1073_pnas_1410785111 crossref_primary_10_1016_j_jid_2016_05_122 crossref_primary_10_1016_j_omtm_2020_11_014 crossref_primary_10_3390_ijms18122565 crossref_primary_10_1093_ofid_ofae230 crossref_primary_10_1038_mt_2016_43 crossref_primary_10_1111_cmi_12694 crossref_primary_10_1016_j_virol_2015_02_024 crossref_primary_10_1371_journal_ppat_1005701 crossref_primary_10_1016_j_omtn_2024_102282 crossref_primary_10_1007_s00439_016_1686_2 crossref_primary_10_1089_vim_2017_0055 crossref_primary_10_1038_s41598_017_12308_4 crossref_primary_10_1002_SMMD_20220004 crossref_primary_10_3390_v15040928 |
| Cites_doi | 10.1086/379333 10.1128/JVI.00785-09 10.1073/pnas.95.5.2509 10.1038/mt.2010.302 10.1007/s11908-009-0066-7 10.1128/JVI.00052-12 10.1086/606053 10.1089/104303401450997 10.1086/338231 10.1016/j.str.2010.12.003 10.1128/JVI.70.8.5051-5060.1996 10.1038/nmeth.2177 10.1016/j.nbd.2012.05.005 10.1080/00016340601151949 10.1093/nar/gkl720 10.1001/jama.296.8.964 10.1371/journal.pone.0016825 10.1371/journal.pone.0053217 10.1128/JVI.00166-07 10.1128/JVI.01068-07 10.1056/NEJMoa035144 10.1093/nar/gkl645 10.1128/JVI.79.22.14079-14087.2005 10.1371/journal.pgen.1000683 10.1038/nature08508 10.1038/gt.2012.25 10.1086/591913 10.1073/pnas.97.1.442 10.2144/000113820 10.1128/JVI.01341-07 10.1128/JVI.71.7.5423-5431.1997 10.1126/science.6180477 10.1038/nrmicro1794 10.1056/NEJMoa0904849 10.1016/j.jmb.2005.10.065 10.1074/jbc.M112.379966 10.1128/JVI.72.4.3307-3320.1998 10.1128/JVI.72.7.5343-5350.1998 10.1089/104303403765701187 10.1371/journal.pcbi.1003131 10.1126/science.330.6002.304 10.1016/j.cell.2009.04.021 10.1128/JVI.63.2.943-947.1989 |
| ContentType | Journal Article |
| Copyright | 2014 The American Society of Gene & Cell Therapy Copyright Nature Publishing Group Feb 2014 Copyright © 2014 The American Society of Gene & Cell Therapy 2014 The American Society of Gene & Cell Therapy |
| Copyright_xml | – notice: 2014 The American Society of Gene & Cell Therapy – notice: Copyright Nature Publishing Group Feb 2014 – notice: Copyright © 2014 The American Society of Gene & Cell Therapy 2014 The American Society of Gene & Cell Therapy |
| DBID | 6I. AAFTH AAYXX CITATION NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7TM 5PM DOA |
| DOI | 10.1038/mtna.2013.75 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central - New (Subscription) Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Nucleic Acids Abstracts PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Nucleic Acids Abstracts |
| DatabaseTitleList | PubMed Nucleic Acids Abstracts Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 2162-2531 |
| EndPage | e146 |
| ExternalDocumentID | oai_doaj_org_article_75315e5de9ce43a89af760b711a5b7fd PMC3951911 4088392141 24496438 10_1038_mtna_2013_75 S2162253116302888 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: PL1 HL092557 – fundername: NIAID NIH HHS grantid: U19 AI096111 |
| GroupedDBID | 0R~ 0SF 3V. 53G 5VS 6I. 7X7 88A 88I 8FE 8FH 8FI 8FJ AACTN AAEDW AAFTH AALRI AAXUO ABMAC ABUWG ACGFS ADBBV ADRAZ AEXQZ AFKRA AFTJW AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS AZQEC BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU DIK DWQXO EBS EJD FDB FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE IPNFZ KQ8 LK8 M0L M2P M41 M48 M7P M~E NCXOZ O9- OK1 PIMPY PQQKQ PROAC RIG RNTTT ROL RPM SSZ UKHRP AAMRU AAYWO AAYXX ADVLN AFFHD APXCP CITATION PHGZM PHGZT PQGLB ALIPV NPM 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 PUEGO 7TM 5PM |
| ID | FETCH-LOGICAL-c558t-cfcd0c2270dcd70b6b25d01f3bbd6745f5748c3c1b47b5291b0ac7595cd588383 |
| IEDL.DBID | M2P |
| ISICitedReferencesCount | 45 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000332471000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2162-2531 |
| IngestDate | Fri Oct 03 12:50:30 EDT 2025 Tue Nov 04 01:57:22 EST 2025 Fri Sep 05 09:55:48 EDT 2025 Sun Aug 24 04:11:06 EDT 2025 Tue Oct 07 06:52:54 EDT 2025 Mon Jul 21 06:03:25 EDT 2025 Sat Nov 29 03:19:07 EST 2025 Tue Nov 18 22:36:30 EST 2025 Fri Feb 23 02:33:17 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | endonuclease mutagenesis antiviral |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/3.0 https://www.elsevier.com/tdm/userlicense/1.0 Molecular Therapy-Nucleic Acids is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivative Works 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c558t-cfcd0c2270dcd70b6b25d01f3bbd6745f5748c3c1b47b5291b0ac7595cd588383 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/1796340419?pq-origsite=%requestingapplication% |
| PMID | 24496438 |
| PQID | 1796340419 |
| PQPubID | 2041944 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_75315e5de9ce43a89af760b711a5b7fd pubmedcentral_primary_oai_pubmedcentral_nih_gov_3951911 proquest_miscellaneous_1808630785 proquest_miscellaneous_1499117478 proquest_journals_1796340419 pubmed_primary_24496438 crossref_citationtrail_10_1038_mtna_2013_75 crossref_primary_10_1038_mtna_2013_75 elsevier_sciencedirect_doi_10_1038_mtna_2013_75 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-02-01 |
| PublicationDateYYYYMMDD | 2014-02-01 |
| PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Milwaukee |
| PublicationTitle | Molecular therapy. Nucleic acids |
| PublicationTitleAlternate | Mol Ther Nucleic Acids |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc Elsevier Limited Nature Publishing Group Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited – name: Nature Publishing Group – name: Elsevier |
| References | Knipe, Cliffe (bib23) 2008; 6 Delacôte, Perez, Guyot, Duhamel, Rochon, Ollivier (bib19) 2013; 8 Wang, Lau, Morales, Mont, Straus (bib38) 2005; 79 Goins, Cohen, Glorioso (bib35) 2012; 48 Fox, Aubert (bib47) 2008; 414 Kota, Chivukula, O'Donnell, Wentzel, Montgomery, Hwang (bib44) 2009; 137 Rosen, Morrison, Masri, Brown, Springstubb, Sussman (bib27) 2006; 34 Anderson (bib48) 2001; 26 Corey, Wald, Patel, Sacks, Tyring, Warren (bib7) 2004; 350 Thyme, Jarjour, Takeuchi, Havranek, Ashworth, Scharenberg (bib29) 2009; 461 Sawtell, Poon, Tansky, Thompson (bib37) 1998; 72 Schiffer, Swan, Stone, Jerome (bib30) 2013; 9 Manservigi, Argnani, Marconi (bib34) 2010; 4 Roizman, Knipe, Whitley (bib14) 2007 Serwadda, Gray, Sewankambo, Wabwire-Mangen, Chen, Quinn (bib5) 2003; 188 Halford, Gebhardt, Carr (bib46) 1996; 70 Schiffer, Aubert, Weber, Mintzer, Stone, Jerome (bib11) 2012; 86 Aubert, Ryu, Banks, Rawlings, Scharenberg, Jerome (bib12) 2011; 6 Samaniego, Neiderhiser, DeLuca (bib24) 1998; 72 Wang, Mahalingam, Hoover, Mont, Holland, Cohen (bib39) 2007; 81 Mark, Wald, Magaret, Selke, Olin, Huang (bib41) 2008; 198 Choi, Asokan, Haberman, Samulski (bib45) 2007; Chapter 16 Smith, Grizot, Arnould, Duclert, Epinat, Chames (bib28) 2006; 34 Grosse, Huot, Mahiet, Arnould, Barradeau, Clerre (bib13) 2011; 19 Schiffer, Corey (bib1) 2009; 11 Certo, Gwiazda, Kuhar, Sather, Curinga, Mandt (bib18) 2012; 9 Ferenczy, DeLuca (bib25) 2009; 83 Glatzel, Flechsig, Navarro, Klein, Paterna, Büeler (bib31) 2000; 97 He, Zhou, da Costa, Yu, Kinzler, Vogelstein (bib43) 1998; 95 Celum, Wald, Lingappa, Magaret, Wang, Mugo (bib8) 2010; 362 Fleming, Ginn, Weinberger, Trahair, Smythe, Alexander (bib32) 2001; 12 Berrington, Jerome, Cook, Wald, Corey, Casper (bib3) 2009; 49 Aubert, Chen, Lang, Dang, Fowler, Sloan (bib42) 2008; 82 Wigdahl, Scheck, De Clercq, Rapp (bib15) 1982; 217 Xu, Sternberg, Kottiri, McQuillan, Lee, Nahmias (bib2) 2006; 296 Cohen (bib9) 2010; 330 Tang, Gao, Zhu, Wang, Zhou, Jiang (bib26) 2012; 52 Xu, Gu, Wu, Li, Huang (bib33) 2003; 14 Arnould, Chames, Perez, Lacroix, Duclert, Epinat (bib16) 2006; 355 Valton, Daboussi, Leduc, Molina, Redondo, Macmaster (bib20) 2012; 287 Wald, Link (bib6) 2002; 185 Terry-Allison, Smith, DeLuca (bib40) 2007; 81 Brown, Gardella, Malm, Prober, Forsgren, Krantz (bib4) 2007; 86 van Rensburg, Beyer, Yao, Wang, Denisenko, Li (bib21) 2013; 20 Stoddard (bib10) 2011; 19 Bennardo, Gunn, Cheng, Hasty, Stark (bib17) 2009; 5 Deshmane, Fraser (bib22) 1989; 63 Sawtell (bib36) 1997; 71 Mark (10.1038/mtna.2013.75_bib41) 2008; 198 Schiffer (10.1038/mtna.2013.75_bib11) 2012; 86 He (10.1038/mtna.2013.75_bib43) 1998; 95 Smith (10.1038/mtna.2013.75_bib28) 2006; 34 Terry-Allison (10.1038/mtna.2013.75_bib40) 2007; 81 Anderson (10.1038/mtna.2013.75_bib48) 2001; 26 Schiffer (10.1038/mtna.2013.75_bib1) 2009; 11 Fox (10.1038/mtna.2013.75_bib47) 2008; 414 Sawtell (10.1038/mtna.2013.75_bib37) 1998; 72 Corey (10.1038/mtna.2013.75_bib7) 2004; 350 Goins (10.1038/mtna.2013.75_bib35) 2012; 48 Choi (10.1038/mtna.2013.75_bib45) 2007; Chapter 16 Xu (10.1038/mtna.2013.75_bib33) 2003; 14 Valton (10.1038/mtna.2013.75_bib20) 2012; 287 Knipe (10.1038/mtna.2013.75_bib23) 2008; 6 Cohen (10.1038/mtna.2013.75_bib9) 2010; 330 Certo (10.1038/mtna.2013.75_bib18) 2012; 9 Tang (10.1038/mtna.2013.75_bib26) 2012; 52 Rosen (10.1038/mtna.2013.75_bib27) 2006; 34 Berrington (10.1038/mtna.2013.75_bib3) 2009; 49 Ferenczy (10.1038/mtna.2013.75_bib25) 2009; 83 Halford (10.1038/mtna.2013.75_bib46) 1996; 70 Arnould (10.1038/mtna.2013.75_bib16) 2006; 355 Celum (10.1038/mtna.2013.75_bib8) 2010; 362 Wigdahl (10.1038/mtna.2013.75_bib15) 1982; 217 Thyme (10.1038/mtna.2013.75_bib29) 2009; 461 Stoddard (10.1038/mtna.2013.75_bib10) 2011; 19 Delacôte (10.1038/mtna.2013.75_bib19) 2013; 8 Aubert (10.1038/mtna.2013.75_bib42) 2008; 82 Xu (10.1038/mtna.2013.75_bib2) 2006; 296 Bennardo (10.1038/mtna.2013.75_bib17) 2009; 5 Schiffer (10.1038/mtna.2013.75_bib30) 2013; 9 Serwadda (10.1038/mtna.2013.75_bib5) 2003; 188 Glatzel (10.1038/mtna.2013.75_bib31) 2000; 97 Samaniego (10.1038/mtna.2013.75_bib24) 1998; 72 Wang (10.1038/mtna.2013.75_bib38) 2005; 79 Deshmane (10.1038/mtna.2013.75_bib22) 1989; 63 Aubert (10.1038/mtna.2013.75_bib12) 2011; 6 Fleming (10.1038/mtna.2013.75_bib32) 2001; 12 Grosse (10.1038/mtna.2013.75_bib13) 2011; 19 van Rensburg (10.1038/mtna.2013.75_bib21) 2013; 20 Wang (10.1038/mtna.2013.75_bib39) 2007; 81 Wald (10.1038/mtna.2013.75_bib6) 2002; 185 Brown (10.1038/mtna.2013.75_bib4) 2007; 86 Sawtell (10.1038/mtna.2013.75_bib36) 1997; 71 Kota (10.1038/mtna.2013.75_bib44) 2009; 137 Roizman (10.1038/mtna.2013.75_bib14) 2007 Manservigi (10.1038/mtna.2013.75_bib34) 2010; 4 22718830 - J Virol. 2012 Sep;86(17):8920-36 20089951 - N Engl J Med. 2010 Feb 4;362(5):427-39 17130168 - Nucleic Acids Res. 2006;34(22):e149 17855552 - J Virol. 2007 Nov;81(22):12394-405 9188614 - J Virol. 1997 Jul;71(7):5423-31 23861664 - PLoS Comput Biol. 2013;9(7):e1003131 9620987 - J Virol. 1998 Jul;72(7):5343-50 22401547 - Biotechniques. 2012 Mar;52(3):149-58 17464578 - Acta Obstet Gynecol Scand. 2007;86(5):523-9 2536115 - J Virol. 1989 Feb;63(2):943-7 16971456 - Nucleic Acids Res. 2006;34(17):4791-800 14624374 - J Infect Dis. 2003 Nov 15;188(10):1492-7 22941364 - Nat Methods. 2012 Oct;9(10):973-5 19807272 - Clin Infect Dis. 2009 Nov 1;49(9):1295-301 19524505 - Cell. 2009 Jun 12;137(6):1005-17 22668775 - Neurobiol Dis. 2012 Nov;48(2):255-70 18265393 - Curr Protoc Mol Biol. 2007 Apr;Chapter 16:Unit 16.25 17959661 - J Virol. 2008 Jan;82(2):617-29 16926356 - JAMA. 2006 Aug 23;296(8):964-73 16254342 - J Virol. 2005 Nov;79(22):14079-87 6180477 - Science. 1982 Sep 17;217(4565):1145-6 22740697 - J Biol Chem. 2012 Aug 31;287(36):30139-50 11756980 - J Infect Dis. 2002 Jan 1;185(1):45-52 18264117 - Nat Rev Microbiol. 2008 Mar;6(3):211-21 14702423 - N Engl J Med. 2004 Jan 1;350(1):11-20 19535445 - J Virol. 2009 Sep;83(17 ):8514-24 18783315 - J Infect Dis. 2008 Oct 15;198(8):1141-9 19834534 - PLoS Genet. 2009 Oct;5(10):e1000683 19857385 - Curr Infect Dis Rep. 2009 Nov;11(6):457-64 20835362 - Open Virol J. 2010 Jun 18;4:123-56 19865174 - Nature. 2009 Oct 29;461(7268):1300-4 17459924 - J Virol. 2007 Jul;81(13):6817-26 12828860 - Hum Gene Ther. 2003 Jun 10;14(9):897-906 9482916 - Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14 8764012 - J Virol. 1996 Aug;70(8):5051-60 21220111 - Structure. 2011 Jan 12;19(1):7-15 9525658 - J Virol. 1998 Apr;72(4):3307-20 21399673 - PLoS One. 2011 Feb 09;6(2):e16825 11177545 - Hum Gene Ther. 2001 Jan 1;12(1):77-86 20947733 - Science. 2010 Oct 15;330(6002):304 21224832 - Mol Ther. 2011 Apr;19(4):694-702 10618437 - Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):442-7 16310802 - J Mol Biol. 2006 Jan 20;355(3):443-58 23359797 - PLoS One. 2013;8(1):e53217 18175811 - Methods Mol Biol. 2008;414:47-56 22436965 - Gene Ther. 2013 Feb;20(2):201-14 |
| References_xml | – volume: 97 start-page: 442 year: 2000 end-page: 447 ident: bib31 article-title: Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system publication-title: Proc Natl Acad Sci USA. – volume: 83 start-page: 8514 year: 2009 end-page: 8524 ident: bib25 article-title: Epigenetic modulation of gene expression from quiescent herpes simplex virus genomes publication-title: J Virol – volume: 49 start-page: 1295 year: 2009 end-page: 1301 ident: bib3 article-title: Clinical correlates of herpes simplex virus viremia among hospitalized adults publication-title: Clin Infect Dis – volume: Chapter 16 start-page: Unit 16.25 year: 2007 ident: bib45 article-title: Production of recombinant adeno-associated viral vectors for publication-title: Curr Protoc Mol Biol. – volume: 19 start-page: 694 year: 2011 end-page: 702 ident: bib13 article-title: Meganuclease-mediated inhibition of HSV1 infection in cultured cells publication-title: Mol Ther – volume: 95 start-page: 2509 year: 1998 end-page: 2514 ident: bib43 article-title: A simplified system for generating recombinant adenoviruses publication-title: Proc Natl Acad Sci U S A – volume: 9 start-page: 973 year: 2012 end-page: 975 ident: bib18 article-title: Coupling endonucleases with DNA end-processing enzymes to drive gene disruption publication-title: Nat Methods – volume: 330 start-page: 304 year: 2010 ident: bib9 article-title: Immunology. Painful failure of promising genital herpes vaccine publication-title: Science – volume: 72 start-page: 3307 year: 1998 end-page: 3320 ident: bib24 article-title: Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins publication-title: J Virol – volume: 4 start-page: 123 year: 2010 end-page: 156 ident: bib34 article-title: HSV recombinant vectors for gene therapy publication-title: Open Virol J – volume: 296 start-page: 964 year: 2006 end-page: 973 ident: bib2 article-title: Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States publication-title: JAMA – volume: 86 start-page: 523 year: 2007 end-page: 529 ident: bib4 article-title: Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes publication-title: Acta Obstet Gynecol Scand – volume: 350 start-page: 11 year: 2004 end-page: 20 ident: bib7 article-title: Once-daily valacyclovir to reduce the risk of transmission of genital herpes publication-title: N Engl J Med – volume: 52 start-page: 149 year: 2012 end-page: 158 ident: bib26 article-title: Construction of “small-intelligent” focused mutagenesis libraries using well-designed combinatorial degenerate primers publication-title: Biotechniques – volume: 19 start-page: 7 year: 2011 end-page: 15 ident: bib10 article-title: Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification publication-title: Structure – volume: 8 start-page: e53217 year: 2013 ident: bib19 article-title: High frequency targeted mutagenesis using engineered endonucleases and DNA-end processing enzymes publication-title: PLoS One – volume: 79 start-page: 14079 year: 2005 end-page: 14087 ident: bib38 article-title: Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level publication-title: J Virol – volume: 81 start-page: 6817 year: 2007 end-page: 6826 ident: bib39 article-title: Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia publication-title: J Virol – volume: 20 start-page: 201 year: 2013 end-page: 214 ident: bib21 article-title: Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells publication-title: Gene Ther – start-page: pp. 2502 year: 2007 end-page: pp. 2599 ident: bib14 article-title: Herpes simplex viruses publication-title: Fields Virology – volume: 81 start-page: 12394 year: 2007 end-page: 12405 ident: bib40 article-title: Relaxed repression of herpes simplex virus type 1 genomes in murine trigeminal neurons publication-title: J Virol – volume: 355 start-page: 443 year: 2006 end-page: 458 ident: bib16 article-title: Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets publication-title: J Mol Biol. – volume: 198 start-page: 1141 year: 2008 end-page: 1149 ident: bib41 article-title: Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults publication-title: J Infect Dis – volume: 11 start-page: 457 year: 2009 end-page: 464 ident: bib1 article-title: New concepts in understanding genital herpes publication-title: Curr Infect Dis Rep – volume: 5 start-page: e1000683 year: 2009 ident: bib17 article-title: Limiting the persistence of a chromosome break diminishes its mutagenic potential publication-title: PLoS Genet – volume: 86 start-page: 8920 year: 2012 end-page: 8936 ident: bib11 article-title: Targeted DNA mutagenesis for the cure of chronic viral infections publication-title: J Virol – volume: 185 start-page: 45 year: 2002 end-page: 52 ident: bib6 article-title: Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis publication-title: J Infect Dis – volume: 6 start-page: 211 year: 2008 end-page: 221 ident: bib23 article-title: Chromatin control of herpes simplex virus lytic and latent infection publication-title: Nat Rev Microbiol – volume: 362 start-page: 427 year: 2010 end-page: 439 ident: bib8 article-title: Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 publication-title: N Engl J Med – volume: 188 start-page: 1492 year: 2003 end-page: 1497 ident: bib5 article-title: Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda publication-title: J Infect Dis – volume: 287 start-page: 30139 year: 2012 end-page: 30150 ident: bib20 article-title: 5’-Cytosine-phosphoguanine (CpG) methylation impacts the activity of natural and engineered meganucleases publication-title: J Biol Chem. – volume: 48 start-page: 255 year: 2012 end-page: 270 ident: bib35 article-title: Gene therapy for the treatment of chronic peripheral nervous system pain publication-title: Neurobiol Dis – volume: 70 start-page: 5051 year: 1996 end-page: 5060 ident: bib46 article-title: Mechanisms of herpes simplex virus type 1 reactivation publication-title: J Virol – volume: 6 start-page: e16825 year: 2011 ident: bib12 article-title: Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI publication-title: PLoS One – volume: 461 start-page: 1300 year: 2009 end-page: 1304 ident: bib29 article-title: Exploitation of binding energy for catalysis and design publication-title: Nature – volume: 72 start-page: 5343 year: 1998 end-page: 5350 ident: bib37 article-title: The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation publication-title: J Virol – volume: 9 start-page: e1003131 year: 2013 ident: bib30 article-title: Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach publication-title: PLoS Comput Biol. – volume: 217 start-page: 1145 year: 1982 end-page: 1146 ident: bib15 article-title: High efficiency latency and activation of herpes simplex virus in human cells publication-title: Science – volume: 414 start-page: 47 year: 2008 end-page: 56 ident: bib47 article-title: Flow cytometric detection of activated caspase-3 publication-title: Methods Mol Biol. – volume: 26 start-page: 32 year: 2001 end-page: 46 ident: bib48 article-title: A new method for non-parametric multivariate analysis of variance publication-title: Austral Ecol – volume: 12 start-page: 77 year: 2001 end-page: 86 ident: bib32 article-title: Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons publication-title: Hum Gene Ther – volume: 34 start-page: e149 year: 2006 ident: bib28 article-title: A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences publication-title: Nucleic Acids Res. – volume: 34 start-page: 4791 year: 2006 end-page: 4800 ident: bib27 article-title: Homing endonuclease I-CreI derivatives with novel DNA target specificities publication-title: Nucleic Acids Res. – volume: 82 start-page: 617 year: 2008 end-page: 629 ident: bib42 article-title: The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation publication-title: J Virol – volume: 137 start-page: 1005 year: 2009 end-page: 1017 ident: bib44 article-title: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model publication-title: Cell – volume: 14 start-page: 897 year: 2003 end-page: 906 ident: bib33 article-title: Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors publication-title: Hum Gene Ther – volume: 63 start-page: 943 year: 1989 end-page: 947 ident: bib22 article-title: During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure publication-title: J Virol – volume: 71 start-page: 5423 year: 1997 end-page: 5431 ident: bib36 article-title: Comprehensive quantification of herpes simplex virus latency at the single-cell level publication-title: J Virol – volume: 188 start-page: 1492 year: 2003 ident: 10.1038/mtna.2013.75_bib5 article-title: Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda publication-title: J Infect Dis doi: 10.1086/379333 – volume: 83 start-page: 8514 year: 2009 ident: 10.1038/mtna.2013.75_bib25 article-title: Epigenetic modulation of gene expression from quiescent herpes simplex virus genomes publication-title: J Virol doi: 10.1128/JVI.00785-09 – volume: 95 start-page: 2509 year: 1998 ident: 10.1038/mtna.2013.75_bib43 article-title: A simplified system for generating recombinant adenoviruses publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.5.2509 – volume: 19 start-page: 694 year: 2011 ident: 10.1038/mtna.2013.75_bib13 article-title: Meganuclease-mediated inhibition of HSV1 infection in cultured cells publication-title: Mol Ther doi: 10.1038/mt.2010.302 – volume: 11 start-page: 457 year: 2009 ident: 10.1038/mtna.2013.75_bib1 article-title: New concepts in understanding genital herpes publication-title: Curr Infect Dis Rep doi: 10.1007/s11908-009-0066-7 – volume: 86 start-page: 8920 year: 2012 ident: 10.1038/mtna.2013.75_bib11 article-title: Targeted DNA mutagenesis for the cure of chronic viral infections publication-title: J Virol doi: 10.1128/JVI.00052-12 – volume: 49 start-page: 1295 year: 2009 ident: 10.1038/mtna.2013.75_bib3 article-title: Clinical correlates of herpes simplex virus viremia among hospitalized adults publication-title: Clin Infect Dis doi: 10.1086/606053 – volume: 12 start-page: 77 year: 2001 ident: 10.1038/mtna.2013.75_bib32 article-title: Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons publication-title: Hum Gene Ther doi: 10.1089/104303401450997 – volume: 185 start-page: 45 year: 2002 ident: 10.1038/mtna.2013.75_bib6 article-title: Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis publication-title: J Infect Dis doi: 10.1086/338231 – volume: 19 start-page: 7 year: 2011 ident: 10.1038/mtna.2013.75_bib10 article-title: Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification publication-title: Structure doi: 10.1016/j.str.2010.12.003 – volume: 70 start-page: 5051 year: 1996 ident: 10.1038/mtna.2013.75_bib46 article-title: Mechanisms of herpes simplex virus type 1 reactivation publication-title: J Virol doi: 10.1128/JVI.70.8.5051-5060.1996 – volume: 9 start-page: 973 year: 2012 ident: 10.1038/mtna.2013.75_bib18 article-title: Coupling endonucleases with DNA end-processing enzymes to drive gene disruption publication-title: Nat Methods doi: 10.1038/nmeth.2177 – volume: 48 start-page: 255 year: 2012 ident: 10.1038/mtna.2013.75_bib35 article-title: Gene therapy for the treatment of chronic peripheral nervous system pain publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2012.05.005 – volume: 86 start-page: 523 year: 2007 ident: 10.1038/mtna.2013.75_bib4 article-title: Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes publication-title: Acta Obstet Gynecol Scand doi: 10.1080/00016340601151949 – volume: 34 start-page: e149 year: 2006 ident: 10.1038/mtna.2013.75_bib28 article-title: A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkl720 – volume: 296 start-page: 964 year: 2006 ident: 10.1038/mtna.2013.75_bib2 article-title: Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States publication-title: JAMA doi: 10.1001/jama.296.8.964 – volume: 6 start-page: e16825 year: 2011 ident: 10.1038/mtna.2013.75_bib12 article-title: Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI publication-title: PLoS One doi: 10.1371/journal.pone.0016825 – volume: 8 start-page: e53217 year: 2013 ident: 10.1038/mtna.2013.75_bib19 article-title: High frequency targeted mutagenesis using engineered endonucleases and DNA-end processing enzymes publication-title: PLoS One doi: 10.1371/journal.pone.0053217 – volume: 81 start-page: 6817 year: 2007 ident: 10.1038/mtna.2013.75_bib39 article-title: Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia publication-title: J Virol doi: 10.1128/JVI.00166-07 – volume: 81 start-page: 12394 year: 2007 ident: 10.1038/mtna.2013.75_bib40 article-title: Relaxed repression of herpes simplex virus type 1 genomes in murine trigeminal neurons publication-title: J Virol doi: 10.1128/JVI.01068-07 – volume: 350 start-page: 11 year: 2004 ident: 10.1038/mtna.2013.75_bib7 article-title: Once-daily valacyclovir to reduce the risk of transmission of genital herpes publication-title: N Engl J Med doi: 10.1056/NEJMoa035144 – volume: 34 start-page: 4791 year: 2006 ident: 10.1038/mtna.2013.75_bib27 article-title: Homing endonuclease I-CreI derivatives with novel DNA target specificities publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkl645 – volume: 79 start-page: 14079 year: 2005 ident: 10.1038/mtna.2013.75_bib38 article-title: Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level publication-title: J Virol doi: 10.1128/JVI.79.22.14079-14087.2005 – volume: 5 start-page: e1000683 year: 2009 ident: 10.1038/mtna.2013.75_bib17 article-title: Limiting the persistence of a chromosome break diminishes its mutagenic potential publication-title: PLoS Genet doi: 10.1371/journal.pgen.1000683 – volume: 461 start-page: 1300 year: 2009 ident: 10.1038/mtna.2013.75_bib29 article-title: Exploitation of binding energy for catalysis and design publication-title: Nature doi: 10.1038/nature08508 – start-page: pp. 2502 year: 2007 ident: 10.1038/mtna.2013.75_bib14 article-title: Herpes simplex viruses – volume: 20 start-page: 201 year: 2013 ident: 10.1038/mtna.2013.75_bib21 article-title: Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells publication-title: Gene Ther doi: 10.1038/gt.2012.25 – volume: 198 start-page: 1141 year: 2008 ident: 10.1038/mtna.2013.75_bib41 article-title: Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults publication-title: J Infect Dis doi: 10.1086/591913 – volume: 97 start-page: 442 year: 2000 ident: 10.1038/mtna.2013.75_bib31 article-title: Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.97.1.442 – volume: Chapter 16 start-page: Unit 16.25 year: 2007 ident: 10.1038/mtna.2013.75_bib45 article-title: Production of recombinant adeno-associated viral vectors for in vitro and in vivo use publication-title: Curr Protoc Mol Biol. – volume: 52 start-page: 149 year: 2012 ident: 10.1038/mtna.2013.75_bib26 article-title: Construction of “small-intelligent” focused mutagenesis libraries using well-designed combinatorial degenerate primers publication-title: Biotechniques doi: 10.2144/000113820 – volume: 82 start-page: 617 year: 2008 ident: 10.1038/mtna.2013.75_bib42 article-title: The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation publication-title: J Virol doi: 10.1128/JVI.01341-07 – volume: 71 start-page: 5423 year: 1997 ident: 10.1038/mtna.2013.75_bib36 article-title: Comprehensive quantification of herpes simplex virus latency at the single-cell level publication-title: J Virol doi: 10.1128/JVI.71.7.5423-5431.1997 – volume: 217 start-page: 1145 year: 1982 ident: 10.1038/mtna.2013.75_bib15 article-title: High efficiency latency and activation of herpes simplex virus in human cells publication-title: Science doi: 10.1126/science.6180477 – volume: 6 start-page: 211 year: 2008 ident: 10.1038/mtna.2013.75_bib23 article-title: Chromatin control of herpes simplex virus lytic and latent infection publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro1794 – volume: 362 start-page: 427 year: 2010 ident: 10.1038/mtna.2013.75_bib8 article-title: Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 publication-title: N Engl J Med doi: 10.1056/NEJMoa0904849 – volume: 355 start-page: 443 year: 2006 ident: 10.1038/mtna.2013.75_bib16 article-title: Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets publication-title: J Mol Biol. doi: 10.1016/j.jmb.2005.10.065 – volume: 287 start-page: 30139 year: 2012 ident: 10.1038/mtna.2013.75_bib20 article-title: 5’-Cytosine-phosphoguanine (CpG) methylation impacts the activity of natural and engineered meganucleases publication-title: J Biol Chem. doi: 10.1074/jbc.M112.379966 – volume: 72 start-page: 3307 year: 1998 ident: 10.1038/mtna.2013.75_bib24 article-title: Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins publication-title: J Virol doi: 10.1128/JVI.72.4.3307-3320.1998 – volume: 72 start-page: 5343 year: 1998 ident: 10.1038/mtna.2013.75_bib37 article-title: The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation publication-title: J Virol doi: 10.1128/JVI.72.7.5343-5350.1998 – volume: 4 start-page: 123 year: 2010 ident: 10.1038/mtna.2013.75_bib34 article-title: HSV recombinant vectors for gene therapy publication-title: Open Virol J – volume: 14 start-page: 897 year: 2003 ident: 10.1038/mtna.2013.75_bib33 article-title: Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors publication-title: Hum Gene Ther doi: 10.1089/104303403765701187 – volume: 26 start-page: 32 year: 2001 ident: 10.1038/mtna.2013.75_bib48 article-title: A new method for non-parametric multivariate analysis of variance publication-title: Austral Ecol – volume: 9 start-page: e1003131 year: 2013 ident: 10.1038/mtna.2013.75_bib30 article-title: Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach publication-title: PLoS Comput Biol. doi: 10.1371/journal.pcbi.1003131 – volume: 330 start-page: 304 year: 2010 ident: 10.1038/mtna.2013.75_bib9 article-title: Immunology. Painful failure of promising genital herpes vaccine publication-title: Science doi: 10.1126/science.330.6002.304 – volume: 137 start-page: 1005 year: 2009 ident: 10.1038/mtna.2013.75_bib44 article-title: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model publication-title: Cell doi: 10.1016/j.cell.2009.04.021 – volume: 414 start-page: 47 year: 2008 ident: 10.1038/mtna.2013.75_bib47 article-title: Flow cytometric detection of activated caspase-3 publication-title: Methods Mol Biol. – volume: 63 start-page: 943 year: 1989 ident: 10.1038/mtna.2013.75_bib22 article-title: During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure publication-title: J Virol doi: 10.1128/JVI.63.2.943-947.1989 – reference: 16310802 - J Mol Biol. 2006 Jan 20;355(3):443-58 – reference: 16254342 - J Virol. 2005 Nov;79(22):14079-87 – reference: 11756980 - J Infect Dis. 2002 Jan 1;185(1):45-52 – reference: 9525658 - J Virol. 1998 Apr;72(4):3307-20 – reference: 19834534 - PLoS Genet. 2009 Oct;5(10):e1000683 – reference: 16971456 - Nucleic Acids Res. 2006;34(17):4791-800 – reference: 18265393 - Curr Protoc Mol Biol. 2007 Apr;Chapter 16:Unit 16.25 – reference: 9620987 - J Virol. 1998 Jul;72(7):5343-50 – reference: 19807272 - Clin Infect Dis. 2009 Nov 1;49(9):1295-301 – reference: 22941364 - Nat Methods. 2012 Oct;9(10):973-5 – reference: 9482916 - Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14 – reference: 19535445 - J Virol. 2009 Sep;83(17 ):8514-24 – reference: 8764012 - J Virol. 1996 Aug;70(8):5051-60 – reference: 17464578 - Acta Obstet Gynecol Scand. 2007;86(5):523-9 – reference: 21224832 - Mol Ther. 2011 Apr;19(4):694-702 – reference: 20089951 - N Engl J Med. 2010 Feb 4;362(5):427-39 – reference: 9188614 - J Virol. 1997 Jul;71(7):5423-31 – reference: 21220111 - Structure. 2011 Jan 12;19(1):7-15 – reference: 21399673 - PLoS One. 2011 Feb 09;6(2):e16825 – reference: 12828860 - Hum Gene Ther. 2003 Jun 10;14(9):897-906 – reference: 17855552 - J Virol. 2007 Nov;81(22):12394-405 – reference: 22668775 - Neurobiol Dis. 2012 Nov;48(2):255-70 – reference: 22718830 - J Virol. 2012 Sep;86(17):8920-36 – reference: 14702423 - N Engl J Med. 2004 Jan 1;350(1):11-20 – reference: 23359797 - PLoS One. 2013;8(1):e53217 – reference: 22740697 - J Biol Chem. 2012 Aug 31;287(36):30139-50 – reference: 19857385 - Curr Infect Dis Rep. 2009 Nov;11(6):457-64 – reference: 22401547 - Biotechniques. 2012 Mar;52(3):149-58 – reference: 6180477 - Science. 1982 Sep 17;217(4565):1145-6 – reference: 10618437 - Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):442-7 – reference: 23861664 - PLoS Comput Biol. 2013;9(7):e1003131 – reference: 17459924 - J Virol. 2007 Jul;81(13):6817-26 – reference: 16926356 - JAMA. 2006 Aug 23;296(8):964-73 – reference: 18175811 - Methods Mol Biol. 2008;414:47-56 – reference: 11177545 - Hum Gene Ther. 2001 Jan 1;12(1):77-86 – reference: 18783315 - J Infect Dis. 2008 Oct 15;198(8):1141-9 – reference: 22436965 - Gene Ther. 2013 Feb;20(2):201-14 – reference: 20835362 - Open Virol J. 2010 Jun 18;4:123-56 – reference: 14624374 - J Infect Dis. 2003 Nov 15;188(10):1492-7 – reference: 17130168 - Nucleic Acids Res. 2006;34(22):e149 – reference: 19865174 - Nature. 2009 Oct 29;461(7268):1300-4 – reference: 18264117 - Nat Rev Microbiol. 2008 Mar;6(3):211-21 – reference: 20947733 - Science. 2010 Oct 15;330(6002):304 – reference: 17959661 - J Virol. 2008 Jan;82(2):617-29 – reference: 19524505 - Cell. 2009 Jun 12;137(6):1005-17 – reference: 2536115 - J Virol. 1989 Feb;63(2):943-7 |
| SSID | ssj0000601262 |
| Score | 2.1850579 |
| Snippet | Following acute infection, herpes simplex virus (HSV) establishes latency in sensory neurons, from which it can reactivate and cause recurrent disease.... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e146 |
| SubjectTerms | Adeno-associated virus antiviral endonuclease Herpes simplex virus 1 mutagenesis Original |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQxYELAspjoUVGAi4obOJ3jgW12kqlQqKg3iK_IiJ1HbSbrdR_37GdXe2CCheuySROxuN5xF--QegtFZqSttaFhMcsIN7WhWa6LKRzQhlCtMgkrmfy_FxdXtZft1p9RUxYpgfOiptCOl1xz52vrWdUq1q3UpRGVpXmRrYuet9S1lvFVPbB4HhTN1FSCVIQuMmIei-pms6HECmHKvoxwgu34lGi7d8JS3-mnb-jJ7fC0ckj9HDMI_FRfv7H6J4PT9D-UYAaen6D3-OE7EyfzPeRPw34uhsWPT4N8T-G_BUW9y0-g0wzDHj27Qc2N_giocK9w19WA7gZcILdEidMAdYhChXxv8yILcKzfh4PH8deIJERGWLhU_T95Pji86wY2ysUlnM1FLa1rrSEyNJZJ0sjDOGurFpqjBOS8ZZLpiy1lWHScFJXptRW8ppbx5WCyvYZ2gt98C8QFqz2RhCohixnmjFNLbdCSWlU3LlrJ-jDWsmNHbnHYwuMqybtgVPVxClp4pQ0kk_Qu430r8y5cYfcpzhfG5nIlJ0OgP00o_00_7KfCZquZ7sZk46cTMCtujuGPVgbRTMu-GUDfk1QVoKtT9CbzWlYqnH_RQffr0AGqsuqig0L_iKjoMYEv6tgmOfZzjbvB5lYZE-Dq-WOBe4oYPdM6H4mynAKiTSM_fJ_aOwVegCaYBm6foD2hsXKH6L79nrolovXaR3eAv4nN_A priority: 102 providerName: Directory of Open Access Journals |
| Title | In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease |
| URI | https://dx.doi.org/10.1038/mtna.2013.75 https://www.ncbi.nlm.nih.gov/pubmed/24496438 https://www.proquest.com/docview/1796340419 https://www.proquest.com/docview/1499117478 https://www.proquest.com/docview/1808630785 https://pubmed.ncbi.nlm.nih.gov/PMC3951911 https://doaj.org/article/75315e5de9ce43a89af760b711a5b7fd |
| Volume | 3 |
| WOSCitedRecordID | wos000332471000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2162-2531 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000601262 issn: 2162-2531 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2162-2531 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000601262 issn: 2162-2531 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2162-2531 dateEnd: 20191206 omitProxy: false ssIdentifier: ssj0000601262 issn: 2162-2531 databaseCode: M7P dateStart: 20120101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2162-2531 dateEnd: 20191206 omitProxy: false ssIdentifier: ssj0000601262 issn: 2162-2531 databaseCode: 7X7 dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2162-2531 dateEnd: 20191206 omitProxy: false ssIdentifier: ssj0000601262 issn: 2162-2531 databaseCode: BENPR dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2162-2531 dateEnd: 20191206 omitProxy: false ssIdentifier: ssj0000601262 issn: 2162-2531 databaseCode: PIMPY dateStart: 20120101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2162-2531 dateEnd: 20191206 omitProxy: false ssIdentifier: ssj0000601262 issn: 2162-2531 databaseCode: M2P dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYygMvfA1GYVRGAl5QaGLHsfOENtSpldaqgoHKU-SPBCrRZLTppP333DlpWUHbCy9-SK5xXJ_Pd-dffkfIa55ozopUBxJeM4D9Ng10rMNAOpcow5hOGhLXMzmZqNksnbYJt1ULq9zYRG-oXWUxR94HxUl4HMLDPlz8CrBqFJ6utiU09kgHPJsIIV1jNt3mWJBrhCWsxbuHXPUXdYlkQxF_j8DCazuRJ-zf2ZD-dTj_xk1e24hOH_zvEB6S-60LSo8bnXlE7uTlY3JwXEL4vbiib6kHhfps-wHJRyW9nNfLio5K_ASiSeDSqqBn4KSWNR1-_krNFT33gPLc0fG6BgsF9nO-oh6OQHWJQgF-0omwJDqsFnh5gGVEkEwZttEn5Mvp4PzjMGgrMwRWCFUHtrAutIzJ0FknQ5MYJlwYFdwYl8hYFELGynIbmVgawdLIhNpKkQrrhFIQFD8l-2VV5s8ITeI0NwmDQMqKWMex5lbYRElpFB76FV3ybjNLmW1py7F6xs_MH59zleGcZjinmRRd8mYrfdHQddwgd4ITvpVBkm1_oVp-z9o1C2I8ErlweWrzmGuV6kImoZFRpIWRheuS_kZdstZfafwQeNT8hm6PNpqRtbZilf1Riy55tb0NqxyPbnSZV2uQgcA0irDWwS0yCsJTMNkKujlsFHU7PnDikHgNfi13VHjnD9i9U85_eLZxDj449P389ld_Qe7BGOMGz35E9uvlOn9J7trLer5a9sienEnfqh7pnAwm0089n_3o-QWLrYS2Mx2Np99-A0ORSqw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VggQXXuURKLBIlAsysffhXR8QKtAqUdOoEgH1ZvZhQyRil8Qpyp_iNzJjO6EBtbceuNrjXa89O4_db78h5AWPDWd5YgIFrxmAv00CI0wYKO9jbRkzcUPiOlDDoT4-To42yK_lWRiEVS5tYm2ofelwjbwLihNzEUJjb09-BFg1CndXlyU0GrU4yBY_IWWbvel_gP-7w9j-3uh9L2irCgROSl0FLnc-dIyp0DuvQhtbJn0Y5dxaHyshc6mEdtxFVigrWRLZ0DglE-m81BoSOmj3CrkqkFkMoYLsaLWmg9wmLGYtvj7kujupCiQ3ivhrBDKe8Xx1gYA1B_hvgPs3TvOM49u_9b99stvkZhti091mTtwhG1lxl2ztFqYqJwv6ktag13o3YYtk_YKejqtpSfsFHvFoFqhpmdMBBOFFRXsfP1O7oKMaMJ95ejivwAKDfxjPaA23oKZAoQCPrCLsivbKCV7ewzIpSBYNYcI98ulSBnyfbBZlkT0kNBZJZmMGiaKTwghhuJMu1kpZjZuaeYe8WmpF6lpadqwO8j2t4QFcp6hDKepQqmSH7KykTxo6knPk3qGCrWSQRLy-UE6_pq1NAjEeyUz6LHGZ4EYnJldxaFUUGWlV7juku1TPtI3HmjgLmhqf0-32UhPT1hbO0j9q2CHPV7fBiuHWlCmycg4ykHhHEdZyuEBGQ_oNLklDNw-aibEaHwSpSCwHT6u1KbP2AdbvFONvNZs6hxwD-n508as_I9d7o8NBOugPDx6TGzBe0WD3t8lmNZ1nT8g1d1qNZ9OntUmg5MtlT6jf59agyA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+Inactivation+of+Latent+HSV+by+Targeted+Mutagenesis+Using+an+HSV-specific+Homing+Endonuclease&rft.jtitle=Molecular+therapy.+Nucleic+acids&rft.au=Aubert%2C+Martine&rft.au=Boyle%2C+Nicole+M&rft.au=Stone%2C+Daniel&rft.au=Stensland%2C+Laurence&rft.date=2014-02-01&rft.pub=Elsevier+Inc&rft.issn=2162-2531&rft.eissn=2162-2531&rft.volume=3&rft_id=info:doi/10.1038%2Fmtna.2013.75&rft.externalDocID=S2162253116302888 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-2531&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-2531&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-2531&client=summon |